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Abstract
Reports of the increasing incidence of male infertility paired with decreasing semen quality have triggered studies
on the effects of lifestyle and environmental factors on the male reproductive potential. There are numerous exogenous
and endogenous factors that are able to induce excessive production of reactive oxygen species (ROS) beyond that of
cellular antioxidant capacity, thus causing oxidative stress. In turn, oxidative stress negatively affects male reproductive
functions and may induce infertility either directly or indirectly by affecting the hypothalamus-pituitary-gonadal (HPG)
axis and/or disrupting its crosstalk with other hormonal axes. This review discusses the important exogenous and
endogenous factors leading to the generation of ROS in different parts of the male reproductive tract. It also highlights
the negative impact of oxidative stress on the regulation and cross-talk between the reproductive hormones. It further
describes the mechanism of ROS-induced derangement of male reproductive hormonal profiles that could ultimately
lead to male infertility. An understanding of the disruptive effects of ROS on male reproductive hormones would
encourage further investigations directed towards the prevention of ROS-mediated hormonal imbalances, which in turn
could help in the management of male infertility.
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Background
Over the past 40 years, reports regarding the decline in
semen quality [1–4] and its probable consequences on
male fertility have encouraged studies about the effects
of environment and lifestyle factors on the male repro-
ductive potential. Reactive oxygen species (ROS) pro-
duced by exogenous and endogenous factors are highly
reactive oxygen derivatives with half-lives in the nano-
to milliseconds range. These molecules reportedly play a
key role in altering male reproductive functions [5, 6].
Lifestyle modifications, technological advancements, es-
calating levels of pollution, alcohol consumption, smoking
of cigarettes and vaping, and physical stress are among the
prime exogenous causes of ROS production [7–9]. Also,
multiple mechanisms involving metabolism in the cell
membrane, mitochondria, peroxisomes, and endoplasmic
reticulum can produce endogenous ROS [7, 9].
Antioxidants defend against excessive ROS levels
through enzymatic (superoxide dismutase, catalases, and
peroxidases) and non-enzymatic (vitamins, steroids etc.)
mechanisms [7, 10]. In cases where the imbalance be-
tween oxidants (ROS) and antioxidants leans towards
the oxidants, oxidative stress (OS) occurs, which puts
the cells and the body under stress. As a result, excessive
ROS can induce lipid peroxidation, disrupt DNA, RNA
as well as protein functions in the spermatozoa and
other testicular cells [10].
High ROS levels can increase the possibility of infertil-
ity not only directly by inducing OS, but also indirectly
by acting through the hypothalamic axes of hormone re-
lease [11–13]. ROS reduce male sex hormone levels and
disrupt the hormonal balance that regulates male repro-
ductive functions [14], and thus causes infertility. These
“endocrine disruptors” not only interfere in the commu-
nication between testis and the hypothalamic-pituitary
unit, they also disrupt the cross-talk between the
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hypothalamic-pituitary-gonadal (HPG) axis with other
hypothalamic hormonal axes [15, 16]. The testis, as the
primary male sex organ, is not only concerned with
spermatogenesis, but also with the secretion of several
hormones [17] which are required for regulation of go-
nadotropin secretion, spermatogenesis, formation of
male phenotype during sexual differentiation, and nor-
mal sexual behaviour [18]. Hence, by interfering with
normal hormonal release, ROS disrupt these essential
reproductive functions.
Therefore, this review precisely elucidates (a) the role
of ROS, generated by various exogenous and endogen-
ous factors, in disrupting hormone secretion by interfer-
ing in the endocrine pathways, as well as in their
cross-talk, (b) hormonal regulation of the oxidative sta-
tus of male reproduction, and (c) a possible mechanism
of action of ROS-induced disruption of the male repro-
ductive hormonal profile.
Endocrinology of male fertility
The gonadotropin releasing hormone (GnRH) secreted
by the hypothalamus regulates the release and secretion
of gonadotropins, luteinizing hormone (LH) and
follicle-stimulating hormone (FSH) from anterior pituit-
ary that in turn regulate testicular functions [17]. These
gonadal steroids as well as the pituitary gonadotropins,
via feedback regulatory mechanisms, further establish
physiological homeostasis and maintains normal repro-
ductive functions [14, 17, 19]. FSH receptors are located
on the membrane of Sertoli cells, while those of LH are
on the Leydig cells. They coordinate to synthesize testos-
terone, maintain normal spermatogenesis, sperm health
and density [19–21].
Moreover, other hormones like estradiol (E2) and pro-
lactin (PRL) also take part in the management of male
reproductive function. E2, produced both by the testis
and via the peripheral conversion of androgenic precur-
sors, is a potent inhibitor of LH and FSH [18, 19] (Fig. 1).
PRL-inhibiting GnRH secretion via modulation of dopa-
minergic pathway may also reduce LH and testosterone
level and thus is associated with hypogonadism [22].
Dehydroepiandrosterone (DHEA) is another male
reproduction ameliorating, steroid hormone secreted by
the adrenal cortex [23, 24]. Inhibin A and B, dimeric hor-
mones produced by Sertoli cells, exhibit negative feedback
on FSH secretion and thus also on testicular functions
[25]. Moreover, melatonin (MLT), a tryptophan-derived
hormone of the pineal gland, positively regulates gonado-
tropin and testosterone secretion, and thus aid male
reproductive functions [26, 27]. Anti-Mullerian hormone
(AMH), a dimeric glycoprotein hormone produced in em-
bryonic Sertoli cells, is structurally related to inhibin and
is responsible for regression of Mullerian ducts during the
first 8 weeks of embryogenesis. It reflects Sertoli cell
functions and is inhibited by testosterone under the influ-
ence of LH [28–30]. Interactions between the
hypothalamo-pituitary-thyroid (HPT) and HPG axes
potentially influence testicular development, mostly by
the participation of thyroid hormones and FSH [31].
Thus, besides the central control through the HPG
axis, the major male reproductive hormones act either in-
dividually or via the cross-talks among different endo-
crine axes to influence male reproductive functions.
Consequently, any disruption to these networks may ad-
versely affect male fertility.
Generation of ROS in the male reproductive tract
Reactive oxygen species (ROS), which are short-lived,
unstable, and highly reactive species containing at least
one oxygen atom, are able to snatch electrons from
other molecules to achieve an electronically-stable state.
In this process, the other molecule loses an electron fol-
lowing which a new radical is formed. Subsequently, this
radical reacts with another neighbouring molecule, thus
passing on the radical status via a reaction called ‘radi-
cal-chain reaction’ until two radicals react with one an-
other forming a stable bond. These reactions amplify the
degree of alterations in the cellular structures [32–34].
Human spermatozoa contain abundant mitochondria,
particularly in its midpiece [35]. An NADH-dependent
oxidoreductase (in the inner mitochondrial membrane)
and NAD (P) H-oxidase (in the plasma membrane) are
two main sources of superoxide (O2
●-) [32, 33, 36]. The
majority of ROS generated in human spermatozoa is
O2
●- which is a product of oxidative phosphorylation by
addition of an electron to intracellular oxygen and is
created between complex I and III of the electron trans-
port chain [37]. H2O2 is an uncharged, membrane per-
meable molecule which has been found to be the major
initiator of peroxidative damage of the plasma mem-
branes of germ cells [34]. In the presence of transition
metals, such as iron (Fe3+) and copper, O2
●- and H2O2
can generate the extremely reactive OH• through the
Haber-Weiss reaction, which consist of a reduction of
ferric (Fe3+) to ferrous ion (Fe2+) [38]. In a subsequent
second step, called Fenton reaction, Fe2+ is oxidized by
H2O2 to Fe
3+ whereby hydroxide (OH−) and the most
reactive hydroxyl radical (OH•) are formed. Further-
more, O2
●- has the ability to interact with nitric oxide
(NO) to form peroxynitrite (ONOO−), subsequent reac-
tions of which may lead to either apoptotic or necrotic
cell death [39]. In the male reproductive tract, ROS
finally can be generated by one of these sources accord-
ing to the above-mentioned mechanisms.
In order to produce the immense amount of energy
needed for motility, spermatozoa possess numerous
mitochondria in the mid-piece of the flagellum. In the
mitochondria, disruption of the membrane potential
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leads to electron leakage in the electron transfer chain
and subsequently produces ROS. The Ca2+-dependent
NADPH oxidase, called NOX5 (encoded by the NOX5
gene) was initially detected in the human testis, but was
also found to be present in the acrosomal and mid-piece
regions of human spermatozoa [40]. NOX5 is a major
generator of ROS and could subsequently induce OS.
This enzyme is activated when Ca2+ binds to its cytosolic
N-terminal EF-hand and causes conformational changes
to the cell through OS [41]. Moreover, during spermato-
genesis, the developing spermatozoa extrude their cyto-
plasm. When spermiogenesis is disrupted and/or excess
cytoplasm is not completely extruded (excess residual
cytoplasm), the excess cytoplasm will be retained around
the mid-piece. Since cytoplasm contains the enzymatic
machinery to produce ROS, any hindrance in the elimin-
ation of excess cytoplasm would trigger the production
of intrinsic amounts of ROS in excess, which, in turn,
would lead to oxidative damage of the plasma mem-
brane and sperm DNA [42].
The prostate and seminal vesicles are the major
sources of peroxidase-positive leukocytes (polymorpho-
nuclear leukocytes (50 ∼ 60%) as well as macrophages
(20 ∼ 30%)) [43, 44]. Inflammatory responses trigger
these cells to generate ROS about 100-times more than
it is produced under normal conditions [34, 45, 46]. This
elevated ROS production is a part of the natural defense
mechanisms of these cells, whereby NADPH-production
through the hexose monophosphate shunt is elevated.
Leukocyte participation in inflammation is closely con-
nected with the accompanying leukocytospermia [47], a
condition defined by the World Health Organization
(WHO) as semen samples containing more than one
million peroxidase-positive leukocytes per milliliter of
Fig. 1 Sources of reactive oxygen species (ROS) and their impact on the complex endocrine network regulating male reproduction. a High levels of ROS
impact upon the HPG axis which results in decreased secretion of male reproductive hormones. b Through the HPA axis, ROS increases the release of the
stress hormone cortisol, which through the HPA-HPG axes cross-talk, further decreases LH secretion. c Elevated ROS also affects the HPT axis which results
in decreased T3 production from the thyroid gland, which through the cross-talk between HPT and HPG axes, again decreases testosterone synthesis. ROS
also affects the other endocrine glands which interfere with these endocrine axes to result in decreased testosterone production. Increased oxidative stress
(OS), in different conditions, decreases insulin production from the pancreas which again reduces T3 production from the thyroid gland and through
HPT-HPG axes cross-talk decreases testosterone biosynthesis. ROS production in obesity also increases circulating leptin levels which directly reduces
testosterone synthesis in the testis. Reduced melatonin in OS, and increased production of pro-inflammatory cytokines during reproductive tract infections,
affects the HPG axis to reduce testosterone biosynthesis. OS also increases prolactin secretion from the anterior pituitary and E2 synthesis from the testis.
These two hormones reduce GnRH secretion from the hypothalamus and testosterone biosynthesis from the testis, respectively
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semen [48]. Varicocele, a condition caused by an abnor-
mal dilation of veins in the pampiniform plexus sur-
rounding the spermatic cord [49], is also associated with
elevated levels of seminal ROS [50].
ROS and male reproductive hormones
ROS generation, which can be elicited through various
exogenous and endogenous pathways, may adversely
affect the male reproductive potential by interfering with




Psychological stress has been demonstrated as a cause of
idiopathic male infertility and several studies have
described a correlation between stress and impaired
semen parameters [51–53]. It was reported that psycho-
logical stress can increase the circulating levels of corti-
sol and norepinephrine [54]. These hormones have a
significant impact on increasing intracellular levels of
ROS/reactive nitrogen species (RNS) to have damaging
effects on cellular microstructures and activation of the
immune and inflammatory systems [54, 55]. Psycho-
logical stress inhibits male reproductive functions by dir-
ectly affecting the action of glucocorticoids on Leydig
cells [11]. As a result, circulating testosterone levels de-
crease through suppression of androgen synthesis and
induction of apoptosis of Leydig cells [56]. Psychological
stress can also increase the serum levels of cortico-
sterone (in animals) and cortisol (in humans), which
then enhance the apoptotic frequency of Leydig cells
Table 1 Sources of reactive oxygen species (ROS), their mechanism of generation and effects on male reproductive hormones




By increasing stress hormone (cortisol) levels and activating
the immune–inflammatory system
Decreases serum testosterone and LH levels by suppressing
androgen synthesis and inducing Leydig cells apoptosis
Heat stress By decreasing antioxidant enzyme activities, increasing NADPH
oxidase activity and disrupting mitochondrial homeostasis








By decreasing total antioxidant capacity Decreases serum testosterone and LH levels
Long-term
heavy exercise
By stimulating mitochondrial enzymes including NOX and XO Decreases LH, FSH, and testosterone levels
Obesity By increasing leptin levels in human endothelial cells and
increasing mitochondrial fatty acid oxidation
Activation of the HPG axis stimulates FSH and LH release. Leptin
can directly affect the gonads due to its receptor isoforms in





By decreasing natural food antioxidants and free radical
scavengers
Decreases testosterone biosynthesis, LH secretion and androgen
profile
Alcohol By stimulating cytochrome P450s enzyme activities in the liver,
altering levels of necessary metals in the body, and reducing
antioxidant levels
Increases Sertoli cells and Leydig cells apoptosis, reduces serum
testosterone, LH and FSH levels
Marijuana and
narcotic drugs
By increasing inflammation and cytochrome p53-induced
apoptotic cell death
Inhibits GnRH release and LH production, inhibits HPG axis,
reduces testosterone level, and increases SHBG level
Smoking By decreasing oxygen delivery to the testis and the high
metabolic requirements of spermatogenesis, releasing a large
number of mutagens and metabolites, weakening of the
antioxidant defense systems. Stimulation of NOX enzymes
Alters plasma levels of testosterone, prolactin, estradiol, FSH, LH
and SHBG by affecting the Leydig and Sertoli cells
Anabolic
steroids
By stimulating mitochondrial respiratory chain complexes,
inflammatory cytokine release and cellular apoptosis
Disrupts Leydig cell functions, suppresses HPG axis, reduces LH
release and thus testicular testosterone biosynthesis
Endogenous sources
Aging By decreasing the activities of antioxidant enzymes, alteration
in the mitochondrial membrane potential
Increases lipid peroxidation of Leydig cells, LH sensitivity by
diminishing LH receptors, reduces the rate of steroidogenesis,




Bacterial strains that colonize the male reproductive tract
causes inflammatory damage by inducing leukocyte migration,
release of cytokines and other inflammatory mediators,
activation of macrophages, lymphocytes and other
immunoreactive cells
Reduces serum testosterone levels by disrupting the hormonal
axis, increase in LH and FSH levels
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[57]. Furthermore, during glucocorticoid production
by 11β-hydroxysteroid dehydrogenase-1 (11βHSD-1),
NADPH was produced as a cofactor that is used for
the biosynthesis of steroidogenic enzymes and testos-
terone [58].
Stress adversely affects steroidogenesis, since changes
in the autonomic catecholaminergic activities during
stress may suppress Leydig cell functions, thus inhibiting
steroidogenic enzyme activities and testosterone produc-
tion [11]. Stress-induced elevations of glucocorticoid
levels can directly decrease testosterone levels without
altering LH levels [59–61]. Further, in case of chronic
stress, a decrease in LH and GnRH levels becomes
apparent [62, 63].
Heat stress on gonads
In males, testes are suspended in a scrotum outside the
body in order to keep the temperature 2 to 4 °C lower
than that of core body temperature. This is a require-
ment for normal spermatogenesis [64]. However, heat
stress to the testes not only decreases semen quality but
also indirectly lowers embryo quality after fertilization as
the spermatozoa produced in overheated testis exhibits
damage [65–67]. In this context, heat stress is respon-
sible for enhancing ROS production as well as decreas-
ing antioxidant enzyme activities, increasing NADPH
oxidase activity and disrupting mitochondrial homeosta-
sis [68, 69]. Numerous reports have documented that
factors such as fever, sauna or steam room use, sleeping
posture, long time sitting or driving, polyester-lined ath-
letic supports, using a laptop on the lap and electric
blankets impose negative effects on scrotal temperatures
and subsequently spermatogenesis [70, 71]. Studies have
also reported that clinical conditions such as cryptorchid-
ism, varicocele, and acute febrile illness can increase tes-
ticular temperature and suppress spermatogenesis [70].
Activation of the hypothalamic–pituitary–adrenal (HPA)
axis and the consequent increase in plasma glucocorticoid
concentrations are two of the most important responses to
heat stress. Heat stress imparts detrimental effects on male
reproduction partly by disrupting the normal release of
GnRH from the hypothalamus as well as LH and FSH from
the anterior pituitary gland [72]. Several studies have indi-
cated that testicular heat stress leads to a decline in the
circulating levels of testosterone and LH but increases
serum cortisol levels [73, 74]. Testicular heat stress also
leads to Leydig cell apoptosis and a reduction in testoster-
one biosynthesis in adult rat testes [75]. Moreover, in-
creased testicular temperature adversely affects Sertoli cell
function, production of testicular androgen-binding pro-
tein, spermatogenesis and semen parameters [76]. Thus,
increased heat stress elevates the generation of ROS in the
male reproductive tract by directly affecting cellular metab-
olism [69] and by influencing stress hormone levels [77].
The resulting increase in ROS production, in turn, damages
testicular germ cells and other endocrine cells to disrupt
the hormonal balance, thereby curbing male fertility [34].
Environmental toxicants
Exposure to environmental contaminants adversely af-
fects the male reproductive potential [78, 79]. Male in-
fertility caused by exposure to environmental toxicants
such as cadmium [80, 81], mercury [82, 83], bisphenol A
(BPA) [84, 85] and dioxin [86] is a worldwide problem.
Even chemical components of air pollution can induce
OS by triggering redox-sensitive pathways subsequently
leading to various malaise, such as inflammation and cell
death [87].
These contaminations deteriorate semen parameters,
DNA integrity via disrupting Leydig and Sertoli cell
function, hormone biosynthesis, gene expression and
epigenetic modifications [12, 88, 89]. These toxicants
commonly act as ‘endocrine disrupting chemicals’
(EDCs) that interfere with normal hormonal functions
[90], enhance the level of circulating cortisol owing to
OS induction [91] and reduces circulating testosterone
levels [92, 93]. Increased cortisol decreases LH secretion
through crosstalk between the HPG-HPA axes. De-
creased LH concentration fails to stimulate the Leydig
cells resulting in decreased testosterone production,
whereas decreased FSH affects normal Sertoli cell func-
tions [94]. These toxicants also interfere with the cellular
communications and adhesions between Sertoli–Sertoli
cells and Sertoli–germ cells via the phosphatidylinositol
3-kinase (PI3K)/c-Src/focal adhesion kinase (FAK)
signalling pathway which leads to reproductive dysfunc-
tion [95] and disrupted hormonal secretion. Thus, these
toxicants disrupt normal male reproductive hormonal
balance by their disruptive influence upon the endocrine
and reproductive organs as well as by interfering in the
cross-talk among different endocrine axes [96].
Electromagnetic radiations
Since the last few decades, it has been widely reported
that long-term exposure to electromagnetic radiations
can generate ROS in reproductive organs, which not
only declines motility, viability, and normal morphology
of functional spermatozoa [97, 98], but also disorients
reproductive hormonal profiles. The use of cell phones
[99], wireless internet [100] and other occupational or
environmental radiations [101] are found to be major
causative factors directly augmenting ROS generation in
male reproductive organs [102, 103]. Electromagnetic
radiation affects the HPA axis and increases adrenocorti-
cotropic hormone (ACTH) secretion from the anterior
pituitary thereby increasing the production of cortisol
from adrenal cortex [104]. These radiations can also
decrease testosterone secretion from Leydig cells by
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disrupting the male reproductive hormonal axis [105].
Electromagnetic radiation significantly affect LH levels
but not FSH and PRL levels [106]. It has also been re-
ported that exposure to electromagnetic waves directly
affects the pineal gland, thereby deteriorating the bio-
logical effect of melatonin on GnRH pulse in the hypo-
thalamus [107]. Thus, altered GnRH levels influence
FSH and LH secretion and negatively affects testoster-
one synthesis in the testis [108].
Exercise
Contrary to regular exercise that enhances antioxidant
defences in the body, unaccustomed and/or exhaustive
exercise can lead to the undesirable generation of exces-
sive ROS [109]. Although the exact redox mechanisms
remain elusive, it seems that mitochondria, NADPH oxi-
dase (NOX), and xanthine oxidase (XO) are the major
endogenous sources of ROS in skeletal muscle [109].
Some studies showed that moderate physical activity can
increase FSH, LH, and testosterone levels [110], which is
widely associated with increased energy and muscle
strength [111, 112]. Despite the impact of moderate
exercise, data suggest that vigorous exercise may de-
crease LH, FSH, and testosterone levels as well as semen
parameters [113, 114]. However, other investigators have
reported that testosterone levels remain unaltered fol-
lowing heavy exercise [115, 116].
Obesity
Obesity is a complex health disorder that severely affects
hormonal balance [117]. Obesity disrupts serum levels of
leptin [118], ghrelin [119], adiponectin [120], orexin
[121], obestatin [122] and other metabolic hormone pro-
files [117]. Reportedly, leptin correlates positively with
body fat mass [123, 124] and a leptin-induced generation
of ROS in human endothelial cells result from increased
mitochondrial fatty acid oxidation [123, 124]. The activa-
tion of the HPG axis could be enhanced by leptin and
thus stimulate the release of GnRH, FSH and LH [125].
Moreover, leptin can directly affect the gonads due to its
receptor isoforms in gonadal tissue [125].
Though the impact of ghrelin on serum testosterone
level is contentious [126–128], it is reported that ghrelin
receptors are present in the testis and that ghrelin plays
a key role in testosterone production, but not directly in
spermatogenesis [126]. Increased ROS levels appear to
cause increased levels of ghrelin [129] which may, in
turn, result in obesity and further ROS production.
Serum adiponectin level is negatively correlated with
both testosterone [130] and ROS production [131].
Orexin (hypocretin) is known to stimulate testosterone
production by enhancing the activities of steroidogenic
enzymes in Leydig cells [132]. It is also reported to at-
tenuate ROS-induced cell damage [133]. All these
metabolic hormones either directly or indirectly reduce
the androgen profile in men.
The complex cross-talk among these hormones is
interrupted in obesity, thus causing a massive annihila-
tion of the hormonal milieu, which in turn affects male
reproductive functions. Although there is a body of evi-
dence highlighting the complexity and the multifactorial
effects that obesity has on certain male reproductive
functions, the correlation between obesity and semen
parameters is still debated [134, 135].
Food intake
There is an inverse relationship between the dietary intake
of antioxidant-rich food and incidence of human diseases
[136]. Many naturally-occurring antioxidant compounds
from plant sources have been identified as free radicals or
active oxygen scavengers [136]. Studies show that men
who consume high dietary fish, fruits, vegetables, legumes,
whole grains and omega-3- and omega-6-fatty acids have
better semen parameters compared with men con-
suming high fat, caffeine (> 800 mg/day), red meat,
processed meat, pizza, sugary drinks, and sweets in
their diet [137, 138]. Therefore, in order to compen-
sate for poor nutritional vitamin intake, food and
medicine are routinely supplemented with synthetic
and natural food antioxidants.
It is well-known that chronic high-fat and
high-protein diets lead to an increase in ROS generation
and subsequently OS [139, 140] by disrupting the anti-
oxidant defence [140] and mitochondrial metabolism
[139, 141]. This in turn negatively impacts semen quality
through alteration of hormone levels [142, 143]. Antioxi-
dant therapies may possibly have a beneficial impact on
semen parameters, probably by protecting semen from
ROS, reducing OS and improving basic sperm parame-
ters. This improvement can be established by stimula-
tion of testosterone biosynthesis, FSH and LH secretion,
inhibin B and enhancement of androgen profile [144].
Investigators have showed that mainly selenium, coen-
zyme Q10 (CoQ10), and N-acetyl-cysteine can affect
semen parameters by increasing testosterone and inhibin
B [145]. However, further research is warranted to deter-
mine if there are any appropriate antioxidant com-
pounds as well as suitable doses that could potentially
be used in clinical practice.
Alcohol
Alcohol consumption promotes the generation of ROS
through its metabolism pathway in the liver by stimulat-
ing the activity of cytochrome P450 enzymes, alteration
of certain levels of metals (particularly free iron or cop-
per ions) in the body, and finally, reduction in the anti-
oxidant levels [146]. Due to the critical contribution of
certain metals (particularly iron and copper) to the
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production of hydroxyl radical, anything that increases
the levels of these metals can also promote ROS gener-
ation and OS [147]. It has been reported that alcohol in-
creases iron levels in the body not only by iron-rich
alcoholic beverages, such as red wine, but also by enhan-
cing the absorption of iron from food [148].
Evidences in both animals and humans show that alco-
hol is also associated with high levels of estradiol and
this finds relevance in the fact that estradiol enhances
beta-endorphin release that is conventionally linked with
the effects of alcohol consumption [149]. Chronic alco-
hol consumption can reduce serum testosterone, LH,
and FSH levels by affecting the interactions between the
neural and endocrine systems [149, 150]. Alcohol dis-
rupts the cleavage of GnRH molecule from its precursor
pre-pro GnRH and prevents the movement of protein
kinase C15 which is necessary for the GnRH-stimulation
of LH and FSH [151, 152]. Eventually, this disrupts the
endocrine balance and subsequently affects semen
parameters [153].
Among testicular cells, Sertoli cells are those that are
most affected by chronic alcohol consumption [154].
Since Sertoli cells contribute the most to testicular size,
chronic alcohol abuse eventually causes testicular atro-
phy, degeneration of germ cells, decreased size of lumen
of seminiferous tubules, an abundance of lipid droplets,
vacuoles, dilatation of the blood vessels, variation in
seminal vesicle diameter as well as apoptosis of Sertoli
cells. Due to the intratesticular cross-talk between
Sertoli and Leydig cells, Leydig cells are eventually also
affected by these changes [154, 155]. Though the correl-
ation between alcohol consumption and infertility seems
to be dose-dependent, the threshold of alcohol con-
sumption beyond which would affect male fertility re-
mains ambiguous [156].
Opioids, narcotics and recreational drugs
Opioids administration is associated with disrupted
spermatogenesis and reduced sexual performance [157].
Both endogenous and exogenous opioids inhibit GnRH
secretion, by disrupting the functions of HPG axis [158].
They reportedly generate ROS [159], induce inflamma-
tion as well as aid DNA/chromosomal damages and
apoptosis in cells by p53 [160, 161]. Opioid consumption
leads to increase in serum concentrations of sex hor-
mone binding globulin (SHBG), a protein which tightly
binds testosterone and E2 thus restricting the levels of
unbound testosterone [162, 163]. Therefore, for opioid
users, the level of total testosterone and E2 remain sub-
normal [162, 163]. Consequently, decreased testosterone
levels also result in the decrease of LH levels. The loss
of integrity of the HPG axis via opioid actions on sex
hormones and LH levels, lead to clinical hypogonadism
[162, 164]. The opioid methadone is also reported to
significantly reduce testosterone levels by directly affect-
ing steroidogenesis [158].
Marijuana contains the cannabinoid, delta-9-tetrahy-
drocannabinol (THC), which inhibits GnRH release and
LH production [164]. Thus, THC, by imposing adversities
upon the HPG axis and causing dose-dependent reduction
in testosterone production, impairs spermatogenesis
[164, 165] at different mitotic and meiotic stages,
resulting in several morphogenetic sperm defects as
well as gynecomastia, impaired libido, erectile and
ejaculatory dysfunction [166].
Studies showed that heroin can decrease gonadotropin
and testosterone levels by affecting the HPG axis [158].
Similarly, cocaine exposure can also disrupt normal go-
nadal functions and are associated with decreased testos-
terone production and HPG axis dysregulation [167].
Non-medical use of drug narcotics, such as hydroco-
done and oxycodone can interfere with spermatogenesis
through their effects on the hypothalamus, and suppress
LH release [164].
Smoking
Smoking is a well-known cause of male subfertility/infer-
tility [168]. A major mechanism for this effect appears to
be ROS production by the interference of oxygen delivery
to the testis which compromises the high metabolic re-
quirements of spermatogenesis [168–170]. Smoking also
releases a large number of mutagens and metabolites (in-
cluding radioactive polonium, cadmium, benzopyrene,
carbon monoxide, tar, naphthalene, and aromatic hydro-
carbons) which disrupt the normal structure and function
of the male reproductive organs [168, 169]. It may
enhance OS not only directly through the production of
reactive oxygen radicals in cigarette smoke, but also indir-
ectly through the weakening of the antioxidant defence
systems [171–173]. Studies have indicated that exposure
to smoke can change plasma levels of testosterone, PRL,
E2, FSH, LH and SHBG by effects on Leydig and Sertoli
cells [171–173]. Studies have also shown that smoking is
associated with alterations in semen quality of both fertile
and infertile men by affecting pituitary, thyroid, adrenal
and testicular functions [174].
Anabolic steroids
Regular consumption of exogenous steroids can produce
ROS by disrupting mitochondrial respiratory chain com-
plexes and lead to the release of inflammatory cytokines
and apoptosis [175]. Exogenous steroid hormones inhibit
spermatogenesis by suppressing the HPG axis, thus lim-
iting the release of FSH and LH and in turn decreasing
testosterone biosynthesis in the testis [176, 177]. Hypo-
gonadism associated with anabolic androgenic steroid
(AAS) abuse is usually reversible within 3–6 months
after discontinuation. However, complete recovery takes
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more than 3 years or may even be impossible to achieve
[164]. AAS abuse primarily produces Leydig cell alter-
ations which lead to a decrease in testosterone synthesis
[177]. However, disruption in the end stage of sperm-
atogenesis with a lack of mature spermatozoa (oligo-
zoospermia/ azoospermia), testicular atrophy, and
morphologically-abnormal sperm have been reported
in AAS consumers [178]. Following AAS discontinu-
ation, Leydig cells start further proliferation but cellu-
lar counts generally remain less than normal,
accounting for delayed recovery of testosterone levels
and the occasional irreversible effects of AAS [179].
Endogenous factors
Though endogenous ROS is necessary for normal male
reproductive functions, its excessive production may
interfere with the endocrine axes and their cross-talk.
Aging
In the aged male, Leydig cells are oxidatively damaged due
to excessive generation of endogenous ROS and decreased
concentration and activity of antioxidant enzymes [180].
As a result of excessive ROS generation, oxidative modifi-
cations of DNA and alterations in the mitochondrial
membrane potential required for testosterone synthesis
take place [181, 182]. Alongside these changes, an increase
in LH sensitivity due to diminishing LH receptors per cell
and a reduced ability of LH to activate steroidogenic acute
regulatory (StAR) protein, which transport cholesterol
from the outer mitochondrial membrane to the inner, oc-
curs [183, 184]. Thus, overproduction of ROS may play a
role in age-related testicular degeneration associated with
male infertility [185].
The steroidogenic steps regulated by the P450 enzymes
are the most likely sites of ROS action [186, 187]. FSH
and human chorionic gonadotropin (hCG) together have
been reported to stimulate ROS-producing cellular metab-
olisms affecting differentiation processes in germ cells
[185, 188, 189]. Furthermore, following ROS production,
the activities of several enzymes of the testosterone bio-
synthetic pathway are reduced, resulting in further de-
crease in testosterone synthesis and secretion [190, 191].
Reproductive tract infections
Reproductive tract infections is an important cause of dis-
rupted male reproductive function and infertility [47].
Many immunoregulatory and pro-inflammatory cytokines
are produced by testicular spermatogenic and somatic
cells, both under normal conditions as well as during an
inflammatory scenario [192]. Cytokines (such as IL–1, IL–
6 or TNF-α) are even produced by non-immune cells like
Leydig cells and Sertoli cells, that appear as typical com-
ponents of seminal plasma to maintain normal spermato-
genesis [192, 193]. Reproductive tract infections can be
caused by ejaculatory duct inflammation, epididymitis,
sexually transmitted infections (e.g. gonorrhoea, Chla-
mydia trachomatis, Escherichia coli, mycobacteria and
Ureaplasma urealyticum), urethritis, testicular torsion,
varicocele and several other causes like chronic prostatitis,
inflammation of one or both testes (orchitis), and even by
some drug therapy (escitalopram, tramadol, levonorgestrel
etc.) [47, 194]. With the progression of inflammatory
damage and weakening of antioxidant defence, as a miti-
gation strategy against the colonised bacterial strains,
there can be increased ROS levels in the male genital tract,
affecting the prostate gland, seminal vesicles or the epi-
didymis [47, 195].
Reproductive tract infections indirectly cause germ cell
degeneration and disruption of spermatogenesis through
either of the following occurrences [196]: (i) changes in
testicular temperature following high fever; (ii) conges-
tion of seminiferous tubule following interstitial oedema;
or (iii) modification of testosterone production. Though
studies on male sex hormones and reproductive tract in-
fections are scanty, some investigators observed the re-
duction of testosterone together with an increase in LH
and FSH levels in patients with reproductive tract infec-
tions [196–198]. It has been reported that in patients
with chronic prostatitis, corticosterone level decreases,
while testosterone level increases compared to normal
controls [199]. Whereas in mumps orchitis, increased
corticosterone level decreases both LH and FSH levels
which results in reduced production of testosterone
from Leydig cells [200].
Hormonal influence on the oxidative status of
male reproduction
OS that occurs due to either the enhanced production of
ROS or reduced availability of antioxidants may cause
lipid peroxidation in Leydig cells and germ cells, damage
to lipoproteins, protein aggregation and fragmentation,
and steroidogenic enzyme inhibition [10]. Testicular OS
causes a reduction in testosterone production, either
as a result of the injury to the Leydig cells or to
other endocrine structures like the anterior pituitary
[201, 202]. Reportedly, normal steroidogenesis also
generates ROS, which are largely produced by mito-
chondrial respiration and the catalytic reactions of the
steroidogenic cytochrome P450 enzymes [186]. ROS
generated in this way, in turn, have been identified to
inhibit subsequent steroid productions, and to damage
mitochondrial membranes of spermatozoa [203]. OS
is associated with increased numbers of immature
spermatozoa via an indirect effect on the male
hormone production that is correlated with spermato-
genesis [204, 205].
It has been reported that systemic hormones (FSH,
LH, testosterone, E2, PRL) may regulate seminal total
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antioxidant capacity (TAC) [206, 207]. A positive rela-
tionship between PRL or free T4 (fT4) and a negative
correlation between gonadotropins or gonadal steroids
with TAC have also been shown [22]. It is evident that
some hormones like testosterone and MLT may act as
antioxidants to protect sperm and other testicular cells
from damage induced by ROS [208, 209]. Other metabo-
lites of the steroidogenic pathway like DHEA are
reported to enhance the level of cellular antioxidants,
but the proper mechanism is still unclear [210]. Direct
and indirect relationships between testosterone and anti-
oxidant levels like selenium and/or CoQ10 and between
testosterone and zinc in infertile men, respectively, have
been observed [207, 211]. CoQ10 can decrease FSH and
LH levels [212]. A negative relationship has been found
between serum level of testosterone, E2, fT4 and sperm
DNA damage [213, 214]. Also, the antioxidant inhibition
could affect triiodothyronine (T3), thyroxine (T4), neuro-
transmitter noradrenaline and increase sperm DNA dam-
age [215]. Intramuscular or subcutaneous injection of
highly purified FSH to idiopathic infertile men reduces
ROS production [216] and the subsequent sperm DNA
damage [217]. Although it has been reported that testos-
terone could produce DNA fragmentation in Sertoli and
germ cells by stimulating caspase activities in Sertoli cells
[218], long-term effects of antioxidants can alter FSH, tes-
tosterone, and inhibin B levels [219].
Mechanism of action
Innumerable exogenous and endogenous factors, as dis-
cussed above, can produce ROS in the male reproductive
system by disrupting the balance of oxidants and antiox-
idants. Following the generation of ROS, the HPA axis
becomes activated and releases corticosterone (in ani-
mals) and cortisol (in humans) in response to stress.
These stress hormones, through the cross-talk between
the HPG and HPA axes, negatively affect LH secretion
from the anterior pituitary. Decreased LH fails to stimu-
late Leydig cells to produce enough testosterone.
Decreased FSH diminishes the release of androgen-bind-
ing protein (ABP) from the Sertoli cells, and thus, an
overall decline in circulating testosterone occurs during
severe OS.
ROS also affect HPT axis to reduce T3 and T4 secre-
tion. Decreased T3 reduces the levels of the StAR
mRNA and protein in Leydig cells, as well as testoster-
one production [220]. Increased OS also decreases the
secretion of insulin from the pancreas which further
negatively affects T3 release from the thyroid gland and
thereby testosterone biosynthesis.
Conditions such as obesity not only involve the HPA
and HPT axes, it also includes several metabolic hor-
mones that manifest ROS-induced alterations in male
reproductive functions. Obesity-induced ROS can affect
adipocytes to secrete more leptin, which together with
insulin, negatively regulate T3-release and thereby in-
hibit testicular functions. Leptin, secreted by adipocytes
also inhibit GnRH release from the hypothalamus.
Testicular E2 and inhibin are produced intensely dur-
ing OS, which then inhibit testosterone release. Follow-
ing ROS exposure, aromatase activity increases which
result in more E2 production. ROS exposure is also
reported to increase PRL secretion from anterior pituit-
ary which causes decreased GnRH release. Infections in
the reproductive tract can lead to the production of
pro-inflammatory cytokines (TNF-α, IL-1b, and IL-6)
which again inhibit both GnRH release and testosterone
secretion.
Thus, through its actions on an individual hormonal
axis and/or by disrupting the cross-talk among different
endocrine systems, ROS can lead to decreased testoster-
one production as the outcome of endocrine disruption.
Decreased testosterone fails to regulate spermatogenesis
properly to produce enough mature spermatozoa. It also
fails to maintain the normal growth of accessory repro-
ductive organs which play crucial roles in sperm matur-
ation. As a prime regulator of male reproductive
behaviour, testosterone deficiency may lead to sup-
pressed sexual behaviour among men. Thus, by disrupt-
ing the endocrine reproductive functions, ROS may
result in male infertility (Fig. 1).
Conclusion
This review summarizes the alterations of the reproduct-
ive endocrinological status by numerous endogenous
and exogenous sources of ROS. Pivotal hormonal regula-
tors of male reproductive functions can be affected by
the disruption of the balance between ROS production
and the antioxidant defence mechanism in the male re-
productive system. Uncontrolled generation of ROS may
directly damage reproductive tissues or can interfere
with the normal regulatory mechanisms of the HPG axis
and its crosstalk with other endocrine axes, to adversely
affect male reproductive functioning, thereby inducing
male infertility.
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